Recruiting OBSERVATIONAL NCT06635993
Accuracy of 68Ga-Pentixafor PET/CT for Subtypting Diagnosis in Patients With Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (ABOARD)
Sponsor: Qifu Li
Interventions
68Ga-Pentixafor PET/CT
Updated 1 time since 2024 Last updated: Oct 9, 2024 Started: Aug 12, 2024 Primary completion: Aug 12, 2026 Completion: Aug 12, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06635993, this observational or N/A phase trial focuses on Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion and remains actively recruiting participants. Sponsored by Qifu Li, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Qifu Li
- The Affiliated Hospital Of Southwest Medical University
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- The First Affiliated Hospital of Zhengzhou University
- The Third Xiangya Hospital of Central South University
Data source: Chongqing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .